CME vs FRGE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CME

32.8
AI Score
VS
FRGE Wins

FRGE

54.2
AI Score

Investment Advisor Scores

CME

Oct 22, 2026
33score
Recommendation
AVOID NEW MONEY

FRGE

Oct 22, 2026
54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CME FRGE Winner
Forward P/E 21.9298 0 Tie
PEG Ratio 4.7092 0 Tie
Revenue Growth 0.8% 10.6% FRGE
Earnings Growth 2.5% 0.0% CME
Tradestie Score 32.8/100 54.2/100 FRGE
Profit Margin 63.4% -67.4% CME
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation AVOID NEW MONEY HOLD Tie

Relative Price Performance (Last 90 Days)

CME 1M: +13.0% · 3M: +19.8% FRGE 1M: +0.8% · 3M: +2.0%

Current Technical Phase

CME

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.0% over 20 days), RSI 78

RSI (14): 78.4 · Price: $305.98

FRGE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 69

RSI (14): 69.2 · Price: $45.00

Fundamentals Snapshot

Metric CME FRGE
Market Cap — —
Forward P/E 23.4 -28.5
Trailing P/E 25.1 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 1.0% 1.0%
Operating Margin 0.7% -1.0%
EPS 11.79 -4.90
Dividend Yield 0.02% —

Frequently Asked Questions

Based on our detailed analysis, FRGE is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.